Rapid dEvice Testing pROtocol for Parkinson's Disease

NCT ID: NCT04675853

Last Updated: 2022-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-25

Study Completion Date

2021-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an 8 week observational study to evaluate the feasibility of using remote monitoring technologies in future studies of PD. The study will 2 clinical evaluations (one initial, one final), and an 8-week monitoring period including 4 virtual visits where participants will use a combination of digital devices (Emerald touchless sensor system with associated ankle accelerometer, iPhone, Apple Watch, iPad, Fitbit Aria, FitBit Versa, Withings Blood Pressure Monitor Connect, and/or Withings Sleep Mat) during their daily lives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with PD

No interventions assigned to this group

Care Partners of PD participants

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants with PD

* At least 30 years of age
* Clinical diagnosis of PD by a neurologist or other movement disorder specialist as reported by the participant, with current motor symptoms
* Able to ambulate independently (assistance of minor walking aids such as a cane is permitted, but depending on a walker for ambulation is not)
* Have a BMI of 33 or below calculated by participant reported height and weight at the time of screening
* Able to read, understand, and provide written informed consent in English
* Able, either alone or with a care partner, to operate digital devices
* Have reliable wifi in their home and the ability to connect new devices to their home wifi

Care partners

* At least 18 years of age
* Able to read, understand, and provide written informed consent in English
* Able to operate digital devices
* Care partner for the participant with PD enrolled in the study
* Lives with the participant with PD enrolled in the study
* Able to ambulate independently (assistance of minor walking aids such as a cane is permitted, but depending on a walker for ambulation is not)
* Willing to exclude pet from the participant's bedroom at night for the duration of the study

Exclusion Criteria

Participants with PD

* Any non-PD forms of Parkinsonism
* Active psychiatric disorders that affect the ability to complete study tasks
* Any other medical condition that is the primary cause of the present movement disorder
* Cognitive dysfunction (score \> 7 on the Six-Item Cognitive Impairment Test)
* Considered by the investigator to be an unsuitable participant
* Live in a household with more than three people
* Unwilling to exclude pet from their bedroom at night for the duration of the study

Care partners

* Cognitive dysfunction (score \> 7 on the Six-Item Cognitive Impairment Test)
* Considered by the investigator to be an unsuitable participant
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HealthMode Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mobile Clinical Research Site

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HM041001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.